card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Cell therapy: devising a full clinical development plan

Cell therapy: devising a full clinical development plan
Home / Insights / Cell therapy: devising a full clinical development plan

Laboratory assessments from preclinical research through post-marketing surveillance determine whether a cell-based therapy for cancer succeeds or fails.

Showcasing our IQVIA Connected Intelligence and joint expertise and capabilities, IQVIA Laboratories' Alan Wookey and IQVIA's Diego Correa were recently featured in the peer-reviewed scientific journal Nature to share their thoughts on key components of a comprehensive clinical development plan for cell therapy clinical trials. 

In this paper, Alan and Diego discuss the important role complex laboratory assessments play, from preclinical research through post-market surveillance, in determining the likelihood of success for cell-based therapies for the treatment of cancer. Given the complexities of cell therapy development, Alan and Diego highlight how a thorough plan with collaboration among key expertise from IQVIA and IQVIA Laboratories, customized therapy-specific assays, harmonized oversight of intricate lab assessment timetables throughout the full trial lifecycle and more are keys to success.  

We encourage you to read the full paper here